Alibaba Group said it has agreed to sell medical device and healthcare product categories from Tmall Pharmacy to its Hong Kong-listed healthcare affiliate in return for HK$10.6bn ($1.4bn) in newly issued shares in the latter company.
阿里巴巴集团(Alibaba Group)宣布，已同意将天猫医药馆(Tmall Pharmacy)的医疗器械及保健用品等产品及服务出售给在香港上市的关联企业阿里健康信息技术(Alibaba Health Information Technology)，换取价值106亿港元（合14亿美元）的阿里健康新股。
您已阅读22%（387字），剩余78%（1365字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。